Page last updated: 2024-08-17

edetic acid and Peritoneal Carcinomatosis

edetic acid has been researched along with Peritoneal Carcinomatosis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Bui, C; Lau, KS; Le, K; Mansberg, R; Wong, VCK1
Arafkas, M; Bania, J; Khosrawipour, T; Khosrawipour, V; Kulas, J; Migdal, P; Pigazzi, A; Schubert, J1
Baretton, GB; Grey, A; Hoberück, S; Hölscher, T; Kotzerke, J; Sommer, U1
Burger, IA; Kranzbühler, B; Tran, S; Zilli, T1
Cheung, L; Gano, J; Kavanagh, JJ; Kudelka, AP; Murray, JL; Rosenblum, MG; Verschraegen, CF1

Trials

1 trial(s) available for edetic acid and Peritoneal Carcinomatosis

ArticleYear
Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:5

    Topics: Adult; Aged; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Ascites; Ascitic Fluid; Bone and Bones; Bone Marrow; Bone Marrow Diseases; Carcinoma; Chelating Agents; Chelation Therapy; Dose-Response Relationship, Immunologic; Dose-Response Relationship, Radiation; Edetic Acid; Fallopian Tube Neoplasms; Female; Glycoproteins; Half-Life; Humans; Injections, Intraperitoneal; Mice; Middle Aged; Neoplasm, Residual; Ovarian Neoplasms; Peritoneal Neoplasms; Radiation Injuries; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage; Tissue Distribution; Treatment Outcome; Ytterbium

1999

Other Studies

4 other study(ies) available for edetic acid and Peritoneal Carcinomatosis

ArticleYear
Peritoneal Carcinomatosis From Metastatic Prostate Cancer Identified on 68 Ga-Prostate-Specific Membrane Antigen PET/CT.
    Clinical nuclear medicine, 2023, Aug-01, Volume: 48, Issue:8

    Topics: Aged; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms

2023
Evaluation of Cell-detaching Effect of EDTA in Combination with Oxaliplatin for a Possible Application in HIPEC After Cytoreductive Surgery: A Preliminary in-vitro Study.
    Current pharmaceutical design, 2019, Volume: 25, Issue:45

    Topics: Antineoplastic Agents; Combined Modality Therapy; Cytoreduction Surgical Procedures; Edetic Acid; HT29 Cells; Humans; Hyperthermia, Induced; Neoplasm Recurrence, Local; Neoplasm, Residual; Oxaliplatin; Peritoneal Neoplasms

2019
Rapidly Evolving Diffuse Omental Carcinomatosis of Prostate Cancer in 68Ga-PSMA PET/CT.
    Clinical nuclear medicine, 2021, Apr-01, Volume: 46, Issue:4

    Topics: Aged, 80 and over; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Oligopeptides; Omentum; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms

2021
68Ga-PSMA PET/MR-Positive Peritoneal Metastasis in the Falciform Ligament in Recurrent Prostate Cancer.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:8

    Topics: Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Ligaments; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Oligopeptides; Peritoneal Neoplasms; Positron-Emission Tomography; Prostatic Neoplasms; Recurrence; Risk Factors

2017